SCS
MNTA

Syquant Capital SAS’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Syquant Capital SAS’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,700
Closed -$562K – 116
2020
Q3 		$562K Buy
+10,700
New +$443K 0.29% 48

Syquant Capital SAS's MNTA Position: Q4 2020 in Review

Syquant Capital SAS sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 10,700 shares — an estimated $562K sold.

Syquant Capital SAS first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $562K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Syquant Capital SAS reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Syquant Capital SAS sold 10,700 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $562K.
  • Syquant Capital SAS first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Syquant Capital SAS's Momenta Pharmaceuticals, Inc. position peaked at $562K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Syquant Capital SAS's 13F filing for Q4 2020, filed 5 Feb 2021.